Zoetis | ZTS - Net Income


Zoetis reported $691M in Net Income for its fiscal quarter ending in June of 2026.





Net Income Change Date
AbbVie USD 3.61B 2.92B Jun/2026
Align Technology USD 108.29M 4.48M Jun/2026
Bayer EUR 219M 2.54B Jun/2026
Bristol-Myers Squibb USD 3.32B 640M Jun/2026
Charles River Laboratories USD -1.48M 13.36M Jun/2026
Coherus Biosciences USD -37.64M 2.11M Dec/2025
Dentsply International USD 37M 47M Jun/2026
Eli Lilly USD 7.1B 301M Jun/2026
Henry Schein USD 94M 13M Jun/2026
Idexx Laboratories USD 338.41M 59.97M Jun/2026
Illumina USD 207M 73M Jun/2026
IQVIA Holdings USD 256M 18M Jun/2026
J&J USD 5.53B 299M Jun/2026
Laboratory Of America USD 298.7M 20.9M Jun/2026
Merck USD -1.34B 2.9B Jun/2026
Neogen USD -11.3M 5.7M Mar/2026
Pacira USD 4.65M 1.74M Jun/2026
Perrigo USD 74.5M 473.1M Jun/2026
Pfizer USD -248M 2.94B Jun/2026
Phibro Animal Health USD 27.46M 932K Dec/2025
Quest Diagnostics USD 320M 69M Jun/2026
Sanofi EUR 343M 1.27B Jun/2026
Sanofi EUR 1.61B 2.42B Mar/2026
Zoetis USD 691M 90M Jun/2026